The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P
β¦ LIBER β¦
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease
β Scribed by Stocchi, F.
- Book ID
- 121239138
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 522 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1351-5101
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Rasagiline improves quality of life in p
β
Kevin M. Biglan; Steven Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; T
π
Article
π
2006
π
John Wiley and Sons
π
English
β 164 KB
π 1 views
Early treatment benefits of ropinirole p
β
Bonnie P. Hersh; Nancy L. Earl; Robert A. Hauser; Mark Stacy
π
Article
π
2010
π
John Wiley and Sons
π
English
β 488 KB
π 1 views
A correct balance between endocannabinoid and dopamine-dependent systems is believed to underlie physiological motor control. We measured the levels of the endocannabinoid anandamide in the cerebrospinal fluid of Parkinson's disease (PD) patients. Subjects were divided into three groups: newly diagn
Effects of rasagiline on olfactory funct
β
Haehner, Antje; Hummel, Thomas; Wolz, Martin; KlingelhΓΆfer, Lisa; Fauser, Mareik
π
Article
π
2013
π
John Wiley and Sons
π
English
β 625 KB
Non-motor symptoms in patients with earl
β
Gubanova, E.; Fedorova, N.
π
Article
π
2013
π
Elsevier Science
π
English
β 61 KB
βDASHβ symptoms in patients with Parkins
β
Sharon L. Naismith; Simon J.G. Lewis
π
Article
π
2011
π
Elsevier Science
π
English
β 146 KB
Actigraphy monitoring of symptoms in pat
β
Pan, Weidong; Kwak, Shin; Li, Fuzhong; Wu, Chunlan; Chen, Yiyun; Yamamoto, Yoshi
π
Article
π
2013
π
Elsevier Science
π
English
β 231 KB